Ferreira Juan Camilo Arjona's Net Worth
$2.91 Million
Who is Ferreira Juan Camilo Arjona?
Ferreira Juan Camilo Arjona has an estimated net worth of $2.91 Million. This is based on reported shares in Myovant Sciences Ltd..
SEC CIK
Ferreira Juan Camilo Arjona's CIK is 0001714080
Past Insider Trading and Trends
2020 was Ferreira Juan Camilo Arjona's most active year for acquiring shares with 14 total transactions. Ferreira Juan Camilo Arjona's most active month to acquire stocks was the month of July. 2020 was Ferreira Juan Camilo Arjona's most active year for disposing of shares, totalling 28 transactions. Ferreira Juan Camilo Arjona's most active month to dispose stocks was the month of July. 2021 saw Ferreira Juan Camilo Arjona paying a total of $410,784.00 for 183,718 shares, this is the most they've acquired in one year. In 2021 Ferreira Juan Camilo Arjona cashed out on 126,481 shares for a total of $1,705,388.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Myovant Sciences Ltd. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -246.68K |
—
|
—
|
0
|
Mar 10
| |||
Form 4
| -0.45% | -1.11K |
$26.89 | -$29,821.01 | 246.68K |
Jan 18
| |||
Form 4
| -0.90% | -2.25K |
$26.90 | -$60,551.90 | 247.79K |
Jan 4
| |||
Form 4
| -0.64% | -1.60K |
$25.20 | -$40,420.80 | 250.04K |
Oct 18
| |||
Form 4
| -1.08% | -2.74K |
$24.40 | -$66,807.20 | 251.65K |
Oct 4
| |||
Form 4
| -0.63% | -1.61K |
$12.87 | -$20,669.22 | 254.39K |
Jul 18
| |||
Form 4
| -1.06% | -2.75K |
$13.40 | -$36,917.00 | 255.99K |
Jul 6
| |||
Form 4
| -0.53% | -1.38K |
$10.07 | -$13,916.74 | 258.75K |
May 27
| |||
Form 4
| -1.75% | -4.63K |
$10.45 | -$48,404.40 | 260.13K |
Apr 19
| |||
Form 4
| +64.39% | 103.7K |
—
|
—
| 264.76K |
Apr 15
| |||
Form 4
| -1.18% | -1.92K |
$13.78 | -$26,485.16 | 161.06K |
Apr 5
| |||
Form 4
| -0.83% | -1.36K |
$13.35 | -$18,182.70 | 162.98K |
Mar 1
| |||
Form 4
| -1.36% | -2.27K |
$16.27 | -$36,949.17 | 164.34K |
Jan 4
| |||
Form 4
| -1.17% | -1.98K |
$19.30 | -$38,175.40 | 166.61K |
Nov 29
| |||
Form 4
|
—
|
0
|
$15.90 | -$61,698.00 | 168.59K |
Scheduled
|
Nov 3 - Nov 4
| ||
Form 4
| -1.60% | -2.74K |
$21.62 | -$59,195.56 | 168.59K |
Oct 5
| |||
Form 4
|
—
|
0
|
$16.05 | -$115,780.00 | 171.33K |
Scheduled
|
Sep 27
| ||
Form 4
| -1.14% | -1.98K |
$15.86 | -$386,550.82 | 171.33K |
Scheduled
|
Aug 27 - Aug 30
| ||
Form 4
| -1.58% | -2.78K |
$21.75 | -$60,399.75 | 173.31K |
Jul 7
| |||
Form 4
| -1.00% | -1.78K |
$15.89 | -$63,878.00 | 176.08K |
Scheduled
|
May 28
| ||
Form 4
|
—
|
0
|
$16.01 | -$208,915.00 | 177.87K |
Scheduled
|
May 26
| ||
Form 4
| +40.69% | 51.45K |
—
|
—
| 177.87K |
Apr 15
| |||
Form 4
| -6.03% | -8.11K |
$18.63 | -$151,163.82 | 126.42K |
Apr 6
| |||
Form 4
|
—
|
0
|
$15.98 | -$114,730.00 | 134.53K |
Scheduled
|
Mar 19
| ||
Form 4
| -1.11% | -1.51K |
$22.55 | -$34,118.15 | 134.53K |
Mar 1
| |||
Form 4
|
—
|
0
|
$16.89 | -$36,440.00 | 136.05K |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
$15.85 | -$112,966.27 | 136.05K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
$16.91 | -$182,562.00 | 136.05K |
Scheduled
|
Dec 10
| ||
Form 4
| -1.43% | -1.98K |
$23.65 | -$46,779.70 | 136.05K |
Nov 30
| |||
Form 4
|
—
|
0
|
$13.89 | -$85,540.00 | 138.03K |
Scheduled
|
Nov 17
| ||
Form 4
|
—
|
0
|
$13.89 | -$85,540.00 | 138.03K |
Scheduled
|
Nov 13
| ||
Form 4
|
—
|
0
|
$14.78 | -$97,929.00 | 138.03K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$13.90 | -$138,228.07 | 138.03K |
Scheduled
|
Aug 31
| ||
Form 4
| -4.89% | -7.09K |
$13.43 | -$158,442.54 | 138.03K |
Scheduled
|
Aug 27 - Aug 28
| ||
Form 4
|
—
|
0
|
$13.89 | -$7,759.70 | 145.12K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$13.89 | -$213,190.12 | 145.12K |
Scheduled
|
Jun 24
| ||
Form 4
|
—
|
0
|
$13.89 | -$49,539.88 | 145.12K |
Scheduled
|
Jun 23
| ||
Form 4
| +153.21% | 87.81K |
—
|
—
| 145.12K |
Apr 3
| |||
Form 4
| +488.40% | 47.57K |
—
|
—
| 57.31K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
| -2.60% | -260.00 |
$21.15 | -$5,499.00 | 9.74K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Organon & Co. (OGN) No price found
Head R&D & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +56,368.40% | 7.53K |
$20.15 | -$80,418.65 | 7.54K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||